Compass Pathways plc insider trading
Every open-market purchase and sale by Compass Pathways plc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Does following Compass Pathways plc’s insiders pay?
From March 31, 2022 to September 27, 2024, 5 insiders reported 0 open-market purchases and 5 sales not made under a pre-set plan in Compass Pathways plc. After sales, the shares moved −14.0% against the index over 12 months (a negative figure means selling was the right call).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Atai Life Sciences AG | 10% owner | 0 | — | — | 1 | −22.7% (1) | September 27, 2024 |
| Goldsmith George Jay | Chief Executive Officer | 0 | — | — | 1 | −11.8% (1) | March 31, 2022 |
| Jenkins Annalisa | Director | 0 | — | — | 1 | −11.8% (1) | March 31, 2022 |
| Malievskaia Ekaterina | Chief Innovation Officer | 0 | — | — | 1 | −11.8% (1) | March 31, 2022 |
| Norton David Y | Director | 0 | — | — | 1 | −11.8% (1) | March 31, 2022 |
When several insiders traded Compass Pathways plc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Compass Pathways plc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 1 selling crowd, +26.1%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| April 29, 2022 | 4 selling | +64.8% | +26.1% | −13.4% |